AlphaMed Press has earned an enviable reputation for creating internationally renowned peer-reviewed journals with globally recognized editorial boards dedicated to advancing knowledge and education in their focused disciplines: THE ONCOLOGIST, devoted to community and hospital-based oncologists and physicians entrusted with cancer patient care; STEM CELLS, the world's first journal devoted to this fast-paced field of research; and STEM CELLS TRANSLATIONAL MEDICINE, bridging stem cell research and clinical trials.


In January 2022, these three journals were entrusted via acquisition to Oxford University Press (OUP). Established in 1586, the non-profit OUP is the world’s largest university press.